http://orcid.org/0000-0002-4353-7110

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2024 | 2023 | 2022 | 2021

2024

De Maria, Giovanni Luigi; Greenwood, John P; Zaman, Azfar G; Carrié, Didier; Coste, Pierre; Valgimigli, Marco; Behan, Miles; Berry, Colin; Erglis, Andrejs; Panoulas, Vasileios F; Van Belle, Eric; Juhl Terkelsen, Christian; Hunziker Munsch, Lukas; Jain, Ajay K; Lassen, Jens Flensted; Palmer, Nick; Stone, Gregg W; Banning, Adrian P (2024). Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The PiCSO-AMI-I Trial. Circulation. Cardiovascular interventions, 17(4), e013675. American Heart Association 10.1161/CIRCINTERVENTIONS.123.013675

Baber, Usman; Jang, Yangsoo; Oliva, Angelo; Cao, Davide; Vogel, Birgit; Dangas, George; Sartori, Samantha; Spirito, Alessandro; Smith, Kenneth F; Branca, Mattia; Collier, Timothy; Pocock, Stuart; Valgimigli, Marco; Kim, Byeong-Keuk; Hong, Myeong-Ki; Mehran, Roxana (2024). Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: an Individual Patient Data Meta-analysis of TWILIGHT and TICO Randomized Trials. Circulation, 149(8), pp. 574-584. Lippincott Williams & Wilkins 10.1161/CIRCULATIONAHA.123.067283

2023

Valgimigli, Marco; Aboyans, Victor; Angiolillo, Dominick; Atar, Dan; Capodanno, Davide; Halvorsen, Sigrun; James, Stefan; Jüni, Peter; Kunadian, Vijay; Landi, Antonio; Leonardi, Sergio; Mehran, Roxana; Montalescot, Gilles; Navarese, Eliano Pio; Niebauer, Josef; Oliva, Angelo; Piccolo, Raffaele; Price, Susanna; Storey, Robert F; Völler, Heinz; ... (2023). Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease: 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Association for Acute CardioVascular Care (ACVC) and European Association of Preventive Cardiology (EAPC). European heart journal. Cardiovascular pharmacotherapy, 9(5), pp. 462-496. Oxford University Press 10.1093/ehjcvp/pvad032

Navarese, Eliano Pio; Landi, Antonio; Oliva, Angelo; Piccolo, Raffaele; Aboyans, Victor; Angiolillo, Dominick; Atar, Dan; Capodanno, Davide; Fox, Keith A A; Halvorsen, Sigrun; James, Stefan; Jüni, Peter; Kunadian, Vijay; Leonardi, Sergio; Mehran, Roxana; Montalescot, Gilles; Niebauer, Josef; Price, Susanna; Storey, Robert F; Völler, Heinz; ... (2023). Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease. Two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC) and European Association of Preventive Cardiology (EAPC). European heart journal. Cardiovascular pharmacotherapy, 9(3), pp. 271-290. Oxford University Press 10.1093/ehjcvp/pvad016

Costa, Francesco; Montalto, Claudio; Branca, Mattia; Hong, Sung-Jin; Watanabe, Hirotoshi; Franzone, Anna; Vranckx, Pascal; Hahn, Joo-Yong; Gwon, Hyeon-Cheol; Feres, Fausto; Jang, Yangsoo; De Luca, Giuseppe; Kedhi, Elvin; Cao, Davide; Steg, Philippe Gabriel; Bhatt, Deepak L; Stone, Gregg W; Micari, Antonio; Windecker, Stephan; Kimura, Takeshi; ... (2023). Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials. European Heart Journal, 44(11), pp. 954-968. Oxford University Press 10.1093/eurheartj/ehac706

2022

Valgimigli, Marco; Smits, Pieter C; Frigoli, Enrico; Bongiovanni, Dario; Tijssen, Jan; Hovasse, Thomas; Mafragi, Al; Ruifrok, W T; Karageorgiev, Dimitar; Aminian, Adel; Garducci, Stefano; Merkely, Bela; Routledge, Helen; Ando, Kenji; Fernandez, Josè Francisco Diaz; Cuisset, Thomas; Malik, Fazila Tun Nesa; Halabi, Majdi; Belle, Loic; Din, Jehangir; ... (2022). Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis. European Heart Journal, 43(33), pp. 3100-3114. Oxford University Press 10.1093/eurheartj/ehac284

Lüscher, Thomas F; Davies, Allan; Beer, Juerg H; Valgimigli, Marco; Nienaber, Christoph A; Camm, John A; Baumgartner, Iris; Diener, Hans-Christoph; Konstantinides, Stavros V (2022). Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum. European heart journal, 43(10), pp. 940-958. Oxford University Press 10.1093/eurheartj/ehab642

2021

Van Mieghem, Nicolas M; Unverdorben, Martin; Hengstenberg, Christian; Möllmann, Helge; Mehran, Roxana; López-Otero, Diego; Nombela-Franco, Luis; Moreno, Raul; Nordbeck, Peter; Thiele, Holger; Lang, Irene; Zamorano, José L; Shawl, Fayaz; Yamamoto, Masanori; Watanabe, Yusuke; Hayashida, Kentaro; Hambrecht, Rainer; Meincke, Felix; Vranckx, Pascal; Jin, James; ... (2021). Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR. The New England journal of medicine, 385(23), pp. 2150-2160. Massachusetts Medical Society 10.1056/NEJMoa2111016

Provide Feedback